FATE THERAPEUTICS INC Insider Trading for July 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FATE THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in FATE THERAPEUTICS INC for July 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 30 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.51 | 873 | 19,649 | 11,635 | 12.5 K to 11.6 K (-6.98 %) |
Jul 30 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.50 | 3 | 68 | 12,508 | 12.5 K to 12.5 K (-0.02 %) |
Jul 30 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.50 | 270 | 6,075 | 12,511 | 12.8 K to 12.5 K (-2.11 %) |
Jul 30 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.51 | 596 | 13,414 | 7,949 | 8.5 K to 7.9 K (-6.97 %) |
Jul 30 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.50 | 3 | 68 | 8,545 | 8.5 K to 8.5 K (-0.04 %) |
Jul 30 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.50 | 184 | 4,140 | 8,548 | 8.7 K to 8.5 K (-2.11 %) |
Jul 30 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.51 | 1,696 | 38,172 | 22,605 | 24.3 K to 22.6 K (-6.98 %) |
Jul 30 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.50 | 6 | 135 | 24,301 | 24.3 K to 24.3 K (-0.02 %) |
Jul 30 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.50 | 523 | 11,768 | 24,307 | 24.8 K to 24.3 K (-2.11 %) |
Jul 30 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.51 | 87,010 | 1,958,325 | 1,159,599 | 1.2 M to 1.2 M (-6.98 %) |
Jul 30 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.50 | 317 | 7,133 | 1,246,609 | 1.2 M to 1.2 M (-0.03 %) |
Jul 30 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.50 | 26,852 | 604,170 | 1,246,926 | 1.3 M to 1.2 M (-2.11 %) |
Jul 25 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.51 | 192 | 4,321 | 12,781 | 13 K to 12.8 K (-1.48 %) |
Jul 25 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.51 | 601 | 13,526 | 12,973 | 13.6 K to 13 K (-4.43 %) |
Jul 25 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.51 | 132 | 2,971 | 8,732 | 8.9 K to 8.7 K (-1.49 %) |
Jul 25 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.51 | 411 | 9,250 | 8,864 | 9.3 K to 8.9 K (-4.43 %) |
Jul 25 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.51 | 374 | 8,417 | 24,830 | 25.2 K to 24.8 K (-1.48 %) |
Jul 25 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.51 | 1,167 | 26,263 | 25,204 | 26.4 K to 25.2 K (-4.43 %) |
Jul 25 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.51 | 19,168 | 431,389 | 1,273,778 | 1.3 M to 1.3 M (-1.48 %) |
Jul 25 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.51 | 59,854 | 1,347,014 | 1,292,946 | 1.4 M to 1.3 M (-4.42 %) |
Jul 22 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.52 | 472 | 10,631 | 13,574 | 14 K to 13.6 K (-3.36 %) |
Jul 22 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.50 | 10 | 225 | 14,046 | 14.1 K to 14 K (-0.07 %) |
Jul 22 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.50 | 208 | 4,681 | 14,056 | 14.3 K to 14.1 K (-1.46 %) |
Jul 22 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.52 | 323 | 7,275 | 9,275 | 9.6 K to 9.3 K (-3.37 %) |
Jul 22 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.50 | 7 | 158 | 9,598 | 9.6 K to 9.6 K (-0.07 %) |
Jul 22 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.50 | 142 | 3,196 | 9,605 | 9.7 K to 9.6 K (-1.46 %) |
Jul 22 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.52 | 917 | 20,655 | 26,371 | 27.3 K to 26.4 K (-3.36 %) |
Jul 22 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.50 | 20 | 450 | 27,288 | 27.3 K to 27.3 K (-0.07 %) |
Jul 22 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.50 | 403 | 9,069 | 27,308 | 27.7 K to 27.3 K (-1.45 %) |
Jul 22 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.52 | 46,992 | 1,058,457 | 1,352,800 | 1.4 M to 1.4 M (-3.36 %) |
Jul 22 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.50 | 1,016 | 22,860 | 1,399,792 | 1.4 M to 1.4 M (-0.07 %) |
Jul 22 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 22.50 | 20,656 | 464,849 | 1,400,808 | 1.4 M to 1.4 M (-1.45 %) |
Jul 17 2019 | FATE | FATE THERAPEUTICS ... | Agarwal Shefali | Director | Option Exercise | A | 22.14 | 24,000 | 531,360 | 24,000 |